Previous Page  23 / 35 Next Page
Information
Show Menu
Previous Page 23 / 35 Next Page
Page Background

Page 41

Notes:

allied

academies

Journal of Dermatology Research and Skin Care | Volume 2

May 14-15, 2018 | Montreal, Canada

Spring Dermatology &

Skin Care Expo Conference

Introduction:

The sebaceous glands secretion in acne vulgaris

(AV)iscomposedoflipidswithadecreaseoffreefattyacids(FFA),

especially linoleic acid (AL). It unprotects the glandular epithelial

wall, which is assaulted by FFA hydrolyzed of triglycerides by the

P. acnes lipase. The role of cellular receptors that lead to the

production of nuclear factor kappa B in the etiopathogenesis of

AV has been studied in new therapies clinical trials.

Hypothesis:

Oral supplementation of AL in patients with AV

interferes with the expression of the receptor-activated receiver

proliferator gamma (PPAR-γ).

Methods:

Nineteen patients with papulopustular acne received

for90days:GroupA,300mg/dayoflymecycline;GroupB,540mg

gamalinoleico acids, 510mg linoleic and oleic 1200mg/day;

Group C: groups A+B. In the initial and final visits, inflammatory

lesions biopsies were made for immunohistochemical analysis.

The cells stained with antibody PPAR-γ were analyzed by two

experienced observers and the results grouped into non-

existent expression (0), low (1), medium (2) and high (3) in

the epidermis, sebaceous glands and hair follicles. The results

obtained before and after the treatments were compared,

as well as the groups with each other, with data assessed by

median.

Results:

There was a reduction tendency in the PPARG marking

of the interanexial epithelium in the Group C (median values:

2,5 before and 1,5 after treatment).

Conclusion:

Even though this study has limits inherent to the

restricted sample, it´s seems like lymecyclineworks better when

associated with AL supplementation in the papulopostular acne

treatment.

Speaker Biography

Clarissa Prati is an Italian-Brazilian Dermatologist. She has completed her MSc in

Clinical Medicine. Currently, she is a PhD student in Health Sciences, São Paulo, SP,

Brazil, mentor in Pediatric Dermatology at Pontific Universidade Católica RS/São Lucas

Hospital, Porto Alegre, RS, Brazil. She has also a private office in Porto Alegre, RS,

Brazil, wherein she explores her expertise in clinical and cosmetic dermatology, aside

of being the President of State of Rio Grande do Sul’s Section of the Brazilian Society

of Dermatology.

e:

prati@terra.com.br

Clarissa Prati

Brazilian Society of Dermatology, Brazil

Assessment of cutaneous effects secondary to oral supplementation with omega-3,

-6 and -9 exclusive or associated with tetracycline, in the skin of patients with

papulopustular acne - Preliminary results